Literature DB >> 9501082

Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin.

T Sasaki1, C Brakebusch, J Engel, R Timpl.   

Abstract

Human Mac-2 binding protein (M2BP) was prepared in recombinant form from the culture medium of 293 kidney cells and consisted of a 92 kDa subunit. The protein was obtained in a native state as indicated by CD spectroscopy, demonstrating alpha-helical and beta-type structure, and by protease resistance and immunological analysis. It was highly modified by N- and O-glycosylation but not by glycosaminoglycans. Ultracentrifugation showed non-covalent association into oligomers with molar masses of 1000-1500 kDa. Electron microscopy showed ring-like shapes with diameters of 30-40 nm. M2BP bound in solid-phase assays to collagens IV, V and VI, fibronectin and nidogen, but not to fibrillar collagens I and III or other basement membrane proteins. The protein also mediated adhesion of cell lines at comparable strength with laminin. Adhesion to M2BP was inhibited by antibodies to integrin beta1 subunits but not to alpha2 and alpha6 subunits, RGD peptide or lactose. This distinguishes cell adhesion of M2BP from that of laminin and excludes involvement of lactose-binding galectin-3. Immunological assays demonstrated variable secretion by cultured human cells of M2BP, which was detected in the extracellular matrix of several mouse tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501082      PMCID: PMC1170508          DOI: 10.1093/emboj/17.6.1606

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  Electron microscopy of extracellular matrix components.

Authors:  J Engel
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

2.  Structural characterization of two variants of fibulin-1 that differ in nidogen affinity.

Authors:  T Sasaki; G Kostka; W Göhring; H Wiedemann; K Mann; M L Chu; R Timpl
Journal:  J Mol Biol       Date:  1995-01-20       Impact factor: 5.469

3.  The secreted tumor-associated antigen 90K is a potent immune stimulator.

Authors:  A Ullrich; I Sures; M D'Egidio; B Jallal; T J Powell; R Herbst; A Dreps; M Azam; M Rubinstein; C Natoli
Journal:  J Biol Chem       Date:  1994-07-15       Impact factor: 5.157

4.  Suppression of tumor growth in vivo by local and systemic 90K level increase.

Authors:  B Jallal; J Powell; J Zachwieja; C Brakebusch; L Germain; J Jacobs; S Iacobelli; A Ullrich
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

5.  Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.

Authors:  H Inohara; S Akahani; K Koths; A Raz
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

6.  Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients.

Authors:  G Longo; C Natoli; D Rafanelli; N Tinari; M Morfini; P Rossi-Ferrini; N D'Ostilio; S Iacobelli
Journal:  Br J Haematol       Date:  1993-09       Impact factor: 6.998

7.  Identification of human melanoma cellular and secreted ligands for galectin-3.

Authors:  H Inohara; A Raz
Journal:  Biochem Biophys Res Commun       Date:  1994-06-30       Impact factor: 3.575

8.  LPS-dependent interaction of Mac-2-binding protein with immobilized CD14.

Authors:  B Yu; S D Wright
Journal:  J Inflamm       Date:  1995

9.  Expression of fibulin-2 by fibroblasts and deposition with fibronectin into a fibrillar matrix.

Authors:  T Sasaki; H Wiedemann; M Matzner; M L Chu; R Timpl
Journal:  J Cell Sci       Date:  1996-12       Impact factor: 5.285

10.  Prognostic value of a novel circulating serum 90K antigen in breast cancer.

Authors:  S Iacobelli; P Sismondi; M Giai; M D'Egidio; N Tinari; C Amatetti; P Di Stefano; C Natoli
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

View more
  80 in total

1.  Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.

Authors:  Myoungkun Jeoung; Eun Ryoung Jang; Jinpeng Liu; Chi Wang; Eric C Rouchka; Xiaohong Li; Emilia Galperin
Journal:  Cell Signal       Date:  2016-02-11       Impact factor: 4.315

Review 2.  Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.

Authors:  Ken Shirabe; Yuki Bekki; Dolgormaa Gantumur; Kenichiro Araki; Norihiro Ishii; Atsushi Kuno; Hisashi Narimatsu; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2018-01-09       Impact factor: 7.527

3.  Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen.

Authors:  Ashley S Block; Sarika Saraswati; Cheryl F Lichti; Maha Mahadevan; Alan B Diekman
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

Review 4.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

5.  DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection.

Authors:  C B Bigger; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Role of MSC-derived galectin 3 in the AML microenvironment.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Jared K Burks; YiHua Qiu; Rui-Yu Wang; Elizabeth J Shpall; Leonardo Mirandola; Numsen Hail; Zhihong Zeng; Teresa McQueen; Naval Daver; Sean M Post; Maurizio Chiriva-Internati; Steven M Kornblau; Michael Andreeff
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-04-12       Impact factor: 4.739

7.  Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.

Authors:  Takeji Umemura; Satoru Joshita; Tomohiro Sekiguchi; Yoko Usami; Soichiro Shibata; Takefumi Kimura; Michiharu Komatsu; Akihiro Matsumoto; Masao Ota; Eiji Tanaka
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

Review 8.  Characterization of disease-associated N-linked glycoproteins.

Authors:  Yuan Tian; Hui Zhang
Journal:  Proteomics       Date:  2013-02       Impact factor: 3.984

9.  Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes.

Authors:  Rajaventhan Srirajaskanthan; Martyn E Caplin; Mark G Waugh; Jennifer Watkins; Tim Meyer; J Justin Hsuan; Nicholas J Beaumont
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

10.  Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K.

Authors:  Ji Hee Lee; Myong-Suk Park; Jun-Eul Hwang; Sang-Hee Cho; Woo-Kyun Bae; Hyun-Jeong Shim; Dae-Eun Kim; Ik-Joo Chung
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.